
| Pair Name | Curcumin, Gemcitabine | ||
| Phytochemical Name | Curcumin (PubChem CID: 969516 ) | ||
| Anticancer drug Name | Gemcitabine (PubChem CID: 60750 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Curcumin, Gemcitabine | |||
| Disease Info | [ICD-11: 2C25.Z] | Lung cancer | Investigative | |
| Biological Phenomena | Inhibition-->Epithelial-mesenchymal transition | |||
| Gene Regulation | Down-regulation | Expression | MMP9 | hsa4318 |
| Down-regulation | Expression | VIM | hsa7431 | |
| Down-regulation | Expression | CDH2 | hsa1000 | |
| Up-regulation | Expression | CDH1 | hsa999 | |
| In Vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 |
| In Vivo Model | A549/GEM resistant cells were collected and resuspended with PBS and injected into the tail veins of nude mice. For each mouse, 1×10⁶ cells in 150 μL of PBS were injected. | |||
| Result | Cur reversed GEM resistance and inhibited the EMT process in A549/GEM cells. GEM, combined with Cur, is safe and more effective in the treatment of non-small cell lung cancer. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Curcumin enhances drug sensitivity of gemcitabine-resistant lung cancer cells and inhibits metastasis. Pharmazie. 2021 Nov 1;76(11):538-543. doi: 10.1691/ph.2021.0927. | Click |